US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Overview
Desktop
Wall Street JournalT
TXMD
Therapeuticsmd Inc
1.73
-0.05-2.81%After Hours: 1.650 -0.08 -4.62%19:50 09/06 EDT
OPEN/PREV CLOSE1.820/1.780
TODAY RANGE1.729-1.870
VOL18.14K
MARKET CAP19.95M
52 WEEK RANGE1.430-4.030
AVG VOL (3M)17.52K
% TURNOVER0.16%
TURNOVER--
P/E (TTM)-3.1239
% RANGE7.92%
EPS(TTM)-0.5538
P/E(FORWARD)-4.5526
P/B0.7210
BVPS2.399
DIVIDEND--
P/S15.32
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP19.60M
SHARES OUTSTANDING11.53M
NEXT EARNINGS11/12-11/18
FREE FLOAT11.33M
LOT SIZE1
EX-DIV DATE05/09/2022
News
Press Releases
Financial Reports
Profile
Benzinga·08/26 11:36
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
Investorplace·08/13 01:55
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024
Press release·08/12 23:45
TherapeuticsMD, Inc. Reports Financial Results for the Quarter Ended June 30, 2024
Seeking Alpha·08/12 21:07
Therapeutics MD GAAP EPS of -$0.09
TipRanks·08/12 20:31
TherapeuticsMD Releases Preliminary Quarterly Financial Results
Dow Jones·08/12 20:10
*TherapeuticsMD 2Q License Rev $234,000
Reuters·08/12 20:05
THERAPEUTICSMD INC: QTRLY EPS LOSS FROM CONT OPS $0.09
Seeking Alpha·05/30 20:55
Nektar, Verastem among healthcare additions in Russell Microcap; Assertio, Sangamo removed
Press release·05/11 08:33
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Investorplace·05/11 00:53
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024
TipRanks·05/10 20:34
TherapeuticsMD Releases Preliminary Q1 2024 Financials
Seeking Alpha·05/10 20:17
Therapeutics MD GAAP EPS of -$0.07
Benzinga·05/10 20:07
TherapeuticsMD Q1 EPS $(0.07) Up From $(0.24) YoY
Same Industry
Name/Symbol
Change%
Price